Table 2.
Leukocyte cell‐derived chemotaxin‐2 as a biomarker of disease
| Disease | Findings | Ref. |
|---|---|---|
| Acute liver failure | Potential prognostic indicator | 6 |
| HCC | Potential prognostic indicator | 28, 29, 42 |
| RA | Potential marker for severity of disease | 17, 22 |
| OA | Potential marker of grade and severity of disease | 18 |
| Metabolic syndrome | Potential marker of severity of insulin resistance and obesity | 41 |
| Sepsis | Potential prognostic indicator | 13 |
| Breast cancer | Potential predictor of recurrence and mortality in female smokers | 33 |
HCC, hepatocellular carcinoma; OA, osteoarthritis; RA, rheumatoid arthritis.